| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |